10-K: Amesite Inc. Reports FY2026 Results Amidst Going Concern Doubts

Amesite Inc. filed its annual report for the fiscal year ended June 30, 2026, detailing revenue growth but also highlighting significant net losses and substantial doubt regarding its ability to continue as a going concern.

Summary

• Amesite Inc. reported revenue of $364,777 for the fiscal year ended June 30, 2026, an increase from $110,459 in the prior year, primarily driven by B2B license fees for its NurseMagic app.
• Despite revenue growth, the company incurred a net loss of $3,095,838 for FY2026, compared to a net loss of $3,617,086 in FY2025.
• Management has concluded that there are conditions that raise substantial doubt about the company's ability to continue as a going concern, as it may not have sufficient cash for the next twelve months.
• The company's plans to address this include generating cash through financing transactions, such as common stock offerings, but these are subject to market conditions and not deemed probable.
• Operating expenses remained significant, with General and Administrative expenses at $2,510,264 and Technology and Content Development at $613,578 for FY2026.
• Cash, cash equivalents, and restricted cash totaled $2,398,809 as of June 30, 2026.
• The company is strategically focused on the post-acute healthcare market with its NurseMagic and LynkMagic solutions, having shifted focus away from academic customers.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to the company's continued net losses, substantial doubt about its ability to continue as a going concern, and reliance on future financing.

Positives

• Revenue increased significantly to $364,777 in FY2026 from $110,459 in FY2025, indicating growing market adoption.
• The company secured its largest enterprise deployment to date, serving an approximately 2,700-patient census in fiscal year 2026.
• Operating expenses, including Technology and Content Development and Sales and Marketing, decreased in FY2026 compared to FY2025, contributing to a reduced net loss.
• The company has a clear strategic focus on the healthcare sector with its AI-powered NurseMagic and LynkMagic solutions.
• The B2C NurseMagic app's free version allows for rapid feedback and refinement of features based on real-world usage.

Negatives

• The company incurred a net loss of $3,095,838 in FY2026 and has a history of net losses since inception.
• There is substantial doubt about Amesite Inc.'s ability to continue as a going concern, as management believes it may not have sufficient cash for the next twelve months.
• Future operations are dependent on completing financing transactions, which are not guaranteed and are subject to market conditions.
• The company has not yet established a stable, recurring revenue base sufficient to cover ongoing expenses.
• The company faces significant overhead costs as a public company, regardless of operating results.

Risks

• Compliance and regulatory risks in the highly regulated healthcare sector, including potential penalties for non-compliance with HIPAA, HITECH Act, and emerging AI regulations.
• Adoption, market penetration, and growth risks due to intense competition from established platforms and AI-first entrants.
• Technology, data, and operational risks, including cybersecurity threats, data breaches, and the need for continuous investment in AI innovation and security.
• Financial and business model risks, including the inability to achieve broad adoption, maintain customer base, or realize operational efficiencies.
• General and macroeconomic risks, such as economic downturns, reduced healthcare spending, and disruptions to workforce or supply chain.
• The company's continued viability depends on its ability to adapt to regulatory change, maintain differentiation, and execute its operational and financial plan.
• Failure to manage risks could materially and adversely affect the business, financial condition, and results of operations.
• The company has a history of losses and will need substantial additional funding to continue operations.

Future Outlook

The company's future outlook is heavily dependent on its ability to secure additional financing and achieve broader market adoption of its NurseMagic and LynkMagic solutions. Management plans to generate cash through financing transactions, including stock offerings, but acknowledges these are subject to market conditions and not guaranteed. The company is strategically focused on growing its customer base in the healthcare sector while managing costs.

Management Comments

• We believe that we have a pathway to deliver AI solutions impactfully, quickly, and compliantly across this expansive, underserved segment.
• Adoption by both caregivers and enterprise partners demonstrates the relevance and commercial fit of our technology.
• We believe that we have consistently endeavored to provide strong fiscal discipline, launching and scaling innovative products while managing costs and prioritizing efficient resource allocation.
• Management believes that it may not have sufficient cash and cash equivalents to maintain the Companys planned operations for the next twelve months following the issuance of these financial statements.
• In response to the conditions, management plans include generating cash by completing financing transactions, which may include offerings of common stock.

Industry Context

StockSavvy.ai notes that Amesite operates in the competitive AI-driven healthcare technology space, facing established EMR/EHR vendors, specialized mid-market firms, and emerging AI-first entrants. The company's strategy to focus on post-acute care with NurseMagic and LynkMagic aims to differentiate by combining rapid deployment, practitioner-driven design, and robust compliance, a challenging but potentially rewarding niche.

Comparison to Industry Standards

• The company's revenue of $364,777 for FY2026 is significantly lower than established players in the healthcare IT market, such as Epic Systems or Cerner (now Oracle Health), which generate billions in annual revenue.
• Amesite's net loss of $3,095,838 in FY2026, while reduced from the prior year, highlights the early-stage nature of the company compared to mature, profitable software companies in the healthcare sector.
• The company's focus on AI-powered solutions for documentation and workflow automation aligns with broader industry trends, but its ability to scale and achieve profitability remains a key differentiator against competitors who have already achieved significant market penetration and financial stability.

Legal Proceedings

• The company is not currently a party to or aware of any proceedings that are believed to have, individually or in aggregate, a material adverse effect on its business, financial condition, or results of operations.

Related Party Transactions

• In the January 8, 2025 public offering, the CEO and two Board members purchased an aggregate of 419,999 common stock shares for $1,259,997.
• In April 2026, the CEO invested $250,000 and a Board member invested $350,000 in a private placement on the same economic terms as unaffiliated investors.

Stakeholder Impact

• Shareholders may experience dilution due to future equity issuances to fund operations and potential acquisitions.
• The going concern doubt may negatively impact investor confidence and the stock price.
• Employees' job security could be impacted by the company's financial instability and reliance on future funding.
• Customers in the healthcare sector rely on the company for compliant and reliable AI solutions, and any operational or security failures could disrupt their services.

Next Steps

• Continue to focus on growing the customer base in the post-acute healthcare market.
• Seek to generate cash by completing financing transactions, including offerings of common stock.
• Refine sales and marketing strategies and tactics as products, customer base, and target markets evolve.
• Continue to develop and improve AI-powered solutions for healthcare and professional needs.
• Monitor and ensure compliance with evolving healthcare and data privacy regulations.
• Potentially utilize the At The Market Offering Agreement to raise capital for general corporate and working capital purposes.

Key Dates

Recommendation

The company's continued net losses, substantial doubt about its ability to continue as a going concern, and reliance on uncertain future financing make it a high-risk investment. While revenue is growing, the path to profitability is unclear, and the significant operational and financial risks outweigh the potential positives at this stage.

Keywords

AI solutions, Healthcare technology, NurseMagic, LynkMagic, SaaS, Post-acute care, EMR, HIPAA compliance